Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
INDUSTRY
×
Histamine Antagonists
×
Clear all
Filters
2
NCT06305754
2026-03-13
MK-2870-009
Merck Sharp & Dohme LLC
Phase 3
Recruiting
520 enrolled
NCT06824467
2026-03-13
TroFuse-022
Merck Sharp & Dohme LLC
Phase 3
Recruiting
770 enrolled
NCT06788912
2026-03-10
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2
Recruiting
60 enrolled
NCT05319730
2026-03-02
MK-3475-06B
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
230 enrolled
NCT00719472
2017-05-15
RATE
Genentech, Inc.
Phase 3
Completed
451 enrolled
11 charts